Literature DB >> 11148456

Pathogenesis of beta2-microglobulin amyloidosis.

K Ohashi1.   

Abstract

Hemodialysis-related amyloidosis is a relatively new form of systemic amyloidosis, with beta2-microglobulin (B2M) being identified as the major constituent protein. Most of the clinical findings are related to amyloid deposition in osseo-articular tissues. B2M amyloid deposits first appear in the cervical intervertebral discs, which are well known to be susceptible to mechanical stress. A close relationship between changes of microenvironment caused by such stress and amyloid deposition is highly suggested. In advanced cases, an inflammatory reaction composed of macrophages, multinucleated giant cells, and granulation tissue, is observed around the amyloid deposits. Purified amyloid protein is native B2M, and mutations and proteolysis are not believed to be important for its deposition. Plasma levels of B2M are elevated as much as 5-10 times because of the inability of hemodialysis equipment removal of B2M from blood plasma, the duration being very important for B2M amyloid fibrillogenesis. Heparan sulfate proteoglycans, perlecan, is increased at the same sites of amyloid deposits from the early stages. In B2M amyloidosis, an increase of heparan sulfate proteoglycans is observed in the vascular wall and synovium, but in the discs, ligaments and cartilage, there is an increase of chondroitin sulfate proteoglycans predominantly. B2M has an affinity for heparan sulfate proteoglycans, although it is weaker than that for laminin and type IV collagen. This is related to the interactions between negative charges of sulfate groups of proteoglycans and positive charges of basic amino acids in N-terminal side of B2M. Increased cytokines production in the synovium, induced by advanced glycation end products as well as elevated plasma levels, is also linked to inflammatory reactions. Increased expression of matrix metalloproteinases (MMP), especially MMP-1 and -9, is related to the destructive changes of the bone and cartilage. The decrease of plasma levels by high flux membrane and control of inflammatory reactions are very important for prevention of B2M amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11148456     DOI: 10.1046/j.1440-1827.2001.01156.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  14 in total

1.  Development and evaluation of agents for targeting visceral amyloid.

Authors:  Jonathan S Wall; Alan Solomon; Stephen J Kennel
Journal:  Tijdschr Nucl Geneeskd       Date:  2011-12

2.  Proteomic analyses of human plasma: Venus versus Mars.

Authors:  Christopher C Silliman; Monika Dzieciatkowska; Ernest E Moore; Marguerite R Kelher; Anirban Banerjee; Xiayuan Liang; Kevin J Land; Kirk C Hansen
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

3.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Sallie Macy; Emily B Martin; Angela Williams; Keiichi Higuchi; Stephen J Kennel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

4.  Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.

Authors:  Hirotaka Nakamoto; Chieko Hamada; Tetsutaro Shimaoka; Yoshimi Sekiguchi; Hiroaki Io; Kayo Kaneko; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Artif Organs       Date:  2013-12-14       Impact factor: 1.731

Review 5.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

Review 6.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

Review 7.  Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.

Authors:  Balamurugan Dhayalan; Michael A Weiss
Journal:  Curr Diab Rep       Date:  2022-02-04       Impact factor: 4.810

8.  Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils.

Authors:  Morwenna Y Porter; Katy E Routledge; Sheena E Radford; Eric W Hewitt
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

9.  Cystic beta2-microglobulin amyloidoma in a patient on long-term hemodialysis.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Junko Takahashi; Ken Takahashi; Akira Shiokawa; Takashi Kitanosono; Eriko Kinugasa; Susumu Taguchi
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617

10.  HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release from the MHC-1.

Authors:  John P Hodkinson; Thomas R Jahn; Sheena E Radford; Alison E Ashcroft
Journal:  J Am Soc Mass Spectrom       Date:  2008-10-17       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.